bibliographic entry 1648722 [be/1648722]
https://w3id.org/oc/corpus/be/1648722

is a

• bibliographic reference

content

• Tolcher, A. W, Patnaik, A, Papadopoulos, K. P, Rasco, D. W, Becerra, C. R, Allred, A. J. (2015). Phase I study of the MEK inhibitor trametinib in combination with the AKT inhibitor afuresertib in patients with solid tumors and multiple myeloma. Cancer Chemother. Pharmacol. 75, 183–189. DOI: 10.1007/s00280-014-2615-5 PMID: 25417902

references

• https://w3id.org/oc/corpus/br/2038766